ABBI Insider Trading Activity and SEC Form 4 Filings
ABBI insider trading summary
No open-market insider purchases or sales of Abraxis BioScience, Inc. (ABBI) have been reported on SEC Form 4 in the past 12 months.
Latest ABBI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 13, 2007 | J Frank Harmon | COO of Abraxis Phar. Prod Div. | Sell | $104K (5,000 @ $20.85) |
| Mar 13, 2006 | Stephen Nimer | Director | Buy | $32K (1,072 @ $29.96) |
| Mar 13, 2006 | Stephen Nimer | Director | Buy | $12K (400 @ $29.97) |
| Mar 13, 2006 | Stephen Nimer | Director | Buy | $7K (236 @ $29.99) |
| Mar 13, 2006 | Stephen Nimer | Director | Buy | $3K (92 @ $30.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.